Odeh M, Beny A, Oliven A
Department of Internal Medicine B, Bnai Zion Medical Center, and Technion Faculty of Medicine, Israel Institute of Technology, Haifa.
Am J Med Sci. 2001 Feb;321(2):159-60. doi: 10.1097/00000441-200102000-00009.
Hyponatremia secondary to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) is an uncommon complication of treatment with the new class of antidepressant agents, the selective serotonin reuptake inhibitors (SSRIs). Most of the reported cases were associated with fluoxetine; only 2 have previously been described in association with citalopram. We describe an elderly woman who presented with severe symptomatic hyponatremia caused by the SIADH during therapy with citalopram. Because the use of SSRIs is becoming more popular among elderly depressed patients, the present case and the other 2 reported previously emphasize the need for greater awareness of the development of this serious and potentially fatal complication also in association with citalopram therapy and suggest that serum sodium levels should be monitored closely in elderly patients during treatment with citalopram.
抗利尿激素分泌异常综合征(SIADH)继发的低钠血症是新型抗抑郁药——选择性5-羟色胺再摄取抑制剂(SSRIs)治疗中罕见的并发症。多数报道病例与氟西汀有关;此前仅有2例报道与西酞普兰有关。我们描述了1例老年女性患者,在西酞普兰治疗期间因SIADH出现严重症状性低钠血症。由于SSRIs在老年抑郁症患者中的使用越来越普遍,本病例及之前报道的另外2例强调,对于西酞普兰治疗中出现的这种严重且可能致命的并发症,也需要提高认识,并提示在老年患者西酞普兰治疗期间应密切监测血清钠水平。